Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance.
Physiological data suggest that the direct effect of spinal opiates as well as the activation of adrenergic bulbospinal pathways each results in a reduction in the gain of the stimulus response function in dorsal horn neurons. In its simplest form, this suggests the hypothesis that co-activation of spinal alpha2 and opioid receptors should be manifested as a synergistic interaction in which in its simplest form the net effect would be a product of the effect produced by either drug alone. To assess this hypothesis, rats were prepared with chronically implanted intrathecal (IT) catheters. Dose-response curves for IT morphine were obtained in the presence of fixed doses (0.01 nmol, 0.03 nmol, 0.1 nmol, 0.3 nmol) of 2-[2,6-dimethylphenylamino]-2-imidazoline (ST-91), an alpha 2 agonist. Such concurrent administration of ST-91 resulted in highly significant leftward shifts in the effect of morphine on the hot plate (52.5 degrees C) measure with a significant increase in dose-response curve slopes. To minimize the effects of the cut-off time necessary in an antinociceptive measure, a "Cox proportional hazard" analysis was used. The (log) Hazard function log[h(t)] is expressed as a linear function of the effects resulting from the action of morphine, the action of ST-91 and as a function of an interaction of morphine and ST-91, e.g., the general form is: log[h(t)] = alpha o(t) + beta 1.log doseM + beta 2.log doseST + beta 12.log doseM.log doseST Estimates of the principal coefficients beta 1, beta 2 and beta 12 corresponding to the overall effect of morphine alone, ST-91 alone and the interaction between the two were calculated: beta 1, beta 2 and beta 12. A statistical test of the interaction coefficient revealed that beta 12 was significantly (p less than .001) different from zero, indicating the powerful synergy between IT ST-91 and morphine. Confirmation of the synergistic nature of spinal opioid alpha 2 receptors was provided by the fact that IT injection of naloxone (90 nmol) or phentolamine (100 nmol) after IT injection of various combinations of morphine and ST-91 immediately and completely abolished the potentiating effect of the combination. The clearance of IT [3H]morphine from the thoracic and lumbar spinal cord was not changed in the presence of ST-91. These observations suggest a potent synergistic interaction between spinal mu and alpha 2 adrenergic receptor systems.
Monasky
M S
MS
Laboratory of Neurosurgical Research, Mayo Clinic, Rochester, Minnesota.
Zinsmeister
A R
AR
Stevens
C W
CW
Yaksh
T L
TL
D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use*; D000818:Animals; D003000:Clonidine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004357:Drug Synergism; D007278:Injections, Spinal; D008297:Male; D009020:Morphine / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009270:Naloxone / Q000494:pharmacology; D010146:Pain / Q000188:drug therapy*; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010646:Phentolamine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011930:Reaction Time; D012044:Regression Analysis
D000316:Adrenergic alpha-Agonists; D010277:Parasympathomimetics; D009270:Naloxone; C011266:ST 91; D009020:Morphine; D003000:Clonidine; D010646:Phentolamine